−0.229SEK
−37.07 MSEK
721.00 KSEK
143.45 M
About ISOFOL MEDICAL AB
Sector
CEO
Petter Segelman Lindqvist
Headquarters
Gothenburg
Website
Employees (FY)
3
Founded
2008
ISIN
SE0009581051
FIGI
BBG00GCR2NK6
Isofol Medical AB is a biotech company, which engages in the development of the cancer drug Arfolitixorin, intended primarily for the treatment of colorectal cancer. The company was founded in 2008 by Bengt Gustaf Gustavsson and is headquartered in Gothenburg, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ISOFOL is 0.739 SEK — it has increased by 13.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ISOFOL MEDICAL AB stocks are traded under the ticker ISOFOL.
ISOFOL MEDICAL AB is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
ISOFOL stock is 64.82% volatile and has beta coefficient of −0.12. Check out the list of the most volatile stocks — is ISOFOL MEDICAL AB there?
ISOFOL earnings for the last quarter are −0.33 SEK whereas the estimation was −0.32 SEK which accounts for −2.30% surprise. Estimated earnings for the next quarter are −0.32 SEK. See more details about ISOFOL MEDICAL AB earnings.
ISOFOL MEDICAL AB revenue for the last quarter amounts to 5.00 M SEK despite the estimated figure of 5.00 M SEK. In the next quarter revenue is expected to reach 3.50 M SEK.
Yes, you can track ISOFOL MEDICAL AB financials in yearly and quarterly reports right on TradingView.
ISOFOL stock has fallen by 2.12% compared to the previous week, the month change is a 20.95% rise, over the last year ISOFOL MEDICAL AB has showed a 42.12% increase.
ISOFOL net income for the last quarter is −8.88 M SEK, while the quarter before that showed −6.26 M SEK of net income which accounts for −41.90% change. Track more ISOFOL MEDICAL AB financial stats to get the full picture.
Today ISOFOL MEDICAL AB has the market capitalization of 104.99 M, it has decreased by 10.80% over the last week.
No, ISOFOL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ISOFOL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ISOFOL MEDICAL AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 3.00 employees. See our rating of the largest employees — is ISOFOL MEDICAL AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ISOFOL MEDICAL AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ISOFOL MEDICAL AB stock shows the neutral signal. See more of ISOFOL MEDICAL AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ISOFOL MEDICAL AB EBITDA is −40.95 M SEK, and current EBITDA margin is −5.80 K%. See more stats in ISOFOL MEDICAL AB financial statements.